- Home
- RMBL vs UNCY Comparison
RMBL vs UNCY Comparison
Compare RMBL & UNCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBL
- UNCY
- Stock Information
- Founded
- RMBL 2013
- UNCY 2016
- Country
- RMBL United States
- UNCY United States
- Employees
- RMBL N/A
- UNCY N/A
- Industry
- RMBL EDP Services
- UNCY Biotechnology: Pharmaceutical Preparations
- Sector
- RMBL Technology
- UNCY Health Care
- Exchange
- RMBL Nasdaq
- UNCY Nasdaq
- Market Cap
- RMBL 81.4M
- UNCY 91.0M
- IPO Year
- RMBL N/A
- UNCY 2021
- Fundamental
- Price
- RMBL $2.49
- UNCY $4.64
- Analyst Decision
- RMBL Hold
- UNCY Strong Buy
- Analyst Count
- RMBL 4
- UNCY 4
- Target Price
- RMBL $4.50
- UNCY $63.75
- AVG Volume (30 Days)
- RMBL 224.6K
- UNCY 1.4M
- Earning Date
- RMBL 08-06-2025
- UNCY 08-13-2025
- Dividend Yield
- RMBL N/A
- UNCY N/A
- EPS Growth
- RMBL N/A
- UNCY N/A
- EPS
- RMBL N/A
- UNCY N/A
- Revenue
- RMBL $1,146,100,000.00
- UNCY N/A
- Revenue This Year
- RMBL N/A
- UNCY N/A
- Revenue Next Year
- RMBL $8.09
- UNCY $1,458.53
- P/E Ratio
- RMBL N/A
- UNCY N/A
- Revenue Growth
- RMBL N/A
- UNCY N/A
- 52 Week Low
- RMBL $1.46
- UNCY $2.02
- 52 Week High
- RMBL $7.06
- UNCY $11.00
- Technical
- Relative Strength Index (RSI)
- RMBL 60.71
- UNCY 39.73
- Support Level
- RMBL $2.12
- UNCY $4.76
- Resistance Level
- RMBL $2.43
- UNCY $7.15
- Average True Range (ATR)
- RMBL 0.20
- UNCY 0.98
- MACD
- RMBL 0.06
- UNCY -0.27
- Stochastic Oscillator
- RMBL 85.71
- UNCY 3.48
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include powersports dealership group and vehicle transportation services. The powersports dealership group segment is comprised of powersports dealerships that sell new and pre-owned powersports vehicles; parts, service and accessories; and finance and inventory products for powersports vehicles sold. The vehicle transportation services segment provides nationwide transportation brokerage services between dealerships and auctions.
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.